This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Institute of Organic Chemistry and Biochemistry (Prague) | |
|---|---|
| Name | Institute of Organic Chemistry and Biochemistry |
| Native name | Ústav organické chemie a biochemie |
| Established | 1953 |
| Location | Prague, Czech Republic |
| Parent | Academy of Sciences of the Czech Republic |
Institute of Organic Chemistry and Biochemistry (Prague) is a Prague-based research institute focused on organic chemistry, biochemistry, medicinal chemistry, and chemical biology. The institute is part of the Academy of Sciences of the Czech Republic and interfaces with regional and international institutions such as Charles University, Czech Technical University in Prague, Masaryk University, University of Chemistry and Technology, Prague, and industry partners including Novartis, Roche, Pfizer, and GlaxoSmithKline. Its research programs intersect with topics represented at events like the Gordon Research Conferences, EMBO activities, and meetings of the European Molecular Biology Organization.
The institute was founded during the postwar expansion of scientific institutions in Czechoslovakia alongside entities like the Czechoslovak Academy of Sciences and the Masaryk Institute. Early leaders collaborated with scholars from Charles University and the Czech Technical University in Prague and contributed to national campaigns for scientific modernization paralleling developments in East Germany, Poland, and Hungary. During the late twentieth century the institute adjusted to the political changes following the Velvet Revolution and integrated into the Academy of Sciences of the Czech Republic, enhancing cooperation with Western laboratories such as Max Planck Society institutes, Institut Pasteur, and the University of Cambridge. In the twenty-first century it expanded links with EU initiatives like Horizon 2020 and networks including the European Research Council.
Research groups cover synthetic organic chemistry akin to work at ETH Zurich and University of Oxford, structural studies comparable to the European Molecular Biology Laboratory, and biochemical investigations similar to programs at Harvard University, Massachusetts Institute of Technology, and Stanford University. Departments include Synthetic Organic Chemistry, Structural Chemistry, Biochemistry, Chemical Biology, Medicinal Chemistry, and Computational Chemistry, with thematic intersections with programs at EMBL, Wellcome Trust centres, and Max Planck Institute for Biophysical Chemistry. Principal investigators have collaborations with scientists associated with Nobel Prize laureates, contributors to Nature, Science, and Cell. The institute runs projects aligned with initiatives from the European Molecular Biology Laboratory, European Bioinformatics Institute, and the International Union of Pure and Applied Chemistry.
Onsite resources include high-field nuclear magnetic resonance spectroscopy instruments like those used at Bruker facilities, mass spectrometers comparable to equipment at Thermo Fisher Scientific, X-ray diffraction suites echoing capacities at Diamond Light Source and electron microscopes akin to instruments at EMBL-EBI. The institute maintains compound libraries, biobanks, and high-throughput screening systems with software tools from vendors that serve European Research Area infrastructures and partners such as Czech National Grid. Bioinformatics support links to resources like UniProt, PDB, and GenBank while HPC clusters integrate methods used at CERN computing facilities and regional supercomputing centres.
The institute hosts PhD students, postdoctoral researchers, and visiting scholars from institutions including Charles University, Czech Technical University in Prague, Masaryk University, University of Vienna, University of Oxford, University of Cambridge, and ETH Zurich. Training programs feature joint doctoral agreements with faculties from Charles University and sabbatical exchanges with laboratories at Harvard Medical School and Max Planck Institutes. Seminars attract speakers from EMBO, Royal Society, and recipients of awards such as the Copley Medal and the Wolf Prize. The institute contributes to summer schools and workshops similar to those organized by Cold Spring Harbor Laboratory and the Gordon Research Conferences.
Institutional partnerships span national entities like the Ministry of Education, Youth and Sports (Czech Republic), regional universities, and international research organisations including European Molecular Biology Laboratory, Institut Pasteur, Max Planck Society, Wellcome Trust, and the European Commission. Industry collaborations have included pharmaceutical companies such as Roche, Novartis, Pfizer, AstraZeneca, and biotechnology firms whose alliances mirror consortia supported by Horizon 2020 and Innovative Medicines Initiative. The institute participates in networks with EMBL-EBI, European Bioinformatics Institute, and bilateral projects with groups at University of California, San Francisco, Johns Hopkins University, and ETH Zurich.
Researchers at the institute have published in journals like Nature, Science, Cell, Journal of the American Chemical Society, and Angewandte Chemie International Edition. Contributions include advances in small-molecule synthesis, enzyme mechanism elucidation, and structural characterization of biomolecules, paralleling breakthroughs recognized by prizes such as the F. A. Cotton Award in Synthetic Organic Chemistry, Royal Society of Chemistry medals, and national awards from the Czech Academy of Sciences. Alumni and staff have received grants from the European Research Council, Human Frontier Science Program, and fellowships from EMBO and the Wellcome Trust.
The institute operates under the governance of the Academy of Sciences of the Czech Republic with oversight comparable to governance models at institutions like Max Planck Society institutes and CNRS laboratories. Funding sources combine national funding from ministries, competitive grants from the European Research Council and Horizon Europe, project contracts with pharmaceutical companies including Roche and Novartis, and support from foundations such as the Wellcome Trust and Gates Foundation. Administrative leadership includes a director and scientific council with representation drawn from academia and industry, reflecting practices observed at European Research Council-funded centres and national academies.
Category:Research institutes in the Czech Republic